Basic Information
| LncRNA/CircRNA Name | HAS2-AS1 |
| Synonyms | NA |
| Region | GRCh38_8:121639293-121644693 |
| Ensemble | ENSG00000248690 |
| Refseq | NR_002835 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | glioma tissues |
| Expression Pattern | up-regulated |
| Function Description | In our research, HAS2-AS1 expression was elevated in glioma tissues compared with normal brain tissues |
| Pubmed ID | 30790335 |
| Year | 2019 |
| Title | Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma. |
External Links
| Links for HAS2-AS1 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |